Search for: "Schering AG" Results 1 - 20 of 89
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Mar 2012, 3:55 am by sally
Gedeon Richter plc v Bayer Schering Pharma AG [2012] EWCA Civ 235; [2012] WLR (D) 66 “On an application for the revocation of a registered patent on the ground of obviousness it was sufficient for the judge hearing the case to take an objective view whether a skilled formulator would take the trouble to obtain copies of papers published by inventors or review their contents to ascertain whether the patent in question related to an invention which was novel. [read post]
18 Apr 2012, 9:12 pm by Patent Docs
By Andrew Williams -- In a second case involving the Hatch-Waxman regulatory scheme decided by the Federal Circuit on Monday, the Court held in Bayer Schering Pharma AG v. [read post]
21 Feb 2010, 8:25 pm by Patent Docs
Bayer Schering Pharma AG et al. v. [read post]
3 Mar 2008, 9:38 pm
The original patent owner, Schering AG, and partner Berlex sued Barr in 2005. [read post]
8 Jan 2011, 2:18 pm by Varun Chhonkar
IN/PCT/2002/410/CHE filed by Bayer Schering Pharma, AG claiming contraceptive formulation of drospirenone and ethinylestradiol (EE) marketed as Yasmin and Yaz/Yasminelle in Europe and the US. [read post]
9 Oct 2009, 9:11 am
(patent infringement) 9/15: Bayer Schering Pharma AG, Bayer Healthcare Pharmaceuticals Inc., Schering Corporation v. [read post]
25 Feb 2014, 2:49 pm
 Another example is the German company Schering AG, which lost its U.S. rights in the name Schering during the Second World War. [read post]
8 Jan 2011, 2:18 pm by Varun Chhonkar
IN/PCT/2002/410/CHE filed by Bayer Schering Pharma, AG claiming contraceptive formulation of drospirenone and ethinylestradiol (EE) marketed as Yasmin and Yaz/Yasminelle in Europe and the US. [read post]
6 Feb 2010, 10:14 am by Lawrence B. Ebert
Kazuhiro Sakurada, former Head of Global Drug Discovery Regenerative Medicine Bayer Schering Pharma AG. [read post]
19 Oct 2009, 6:39 am
For $125, Datamonitor will send you a SWOT analysis of Bayer AG. [read post]
25 Jun 2010, 12:06 am by Dane Johnson
Manufacturer Intervet/Schering-Plough Animal Health recently issued a press release announcing the full approval. [read post]
18 Dec 2013, 2:13 pm by Tom Lamb
The plaintiffs contend that Organon and Schering-Plough, among other things, failed to adequately design and manufacture NuvaRing and failed to adequately warn of the alleged increased risk of venous thromboembolism (“VTE”) posed by NuvaRing, and/or downplayed the risk of VTE. [read post]
21 Nov 2011, 8:47 am
According to company e-mails, Bayer AG, Germany’s largest drugmaker, may have tried to market the Yasmin family of birth- control pills for unapproved uses and misled women about the health risks of the drugs. [read post]
3 Mar 2013, 12:06 pm by Rajiv Kr. Choudhry
 402/CHENP/2004 deals with revocation of Schering's patent. [read post]
2 Aug 2009, 8:33 pm
Bayer Schering Pharma AG et al. v. [read post]
18 Mar 2011, 4:31 am by traceydennis
Court of Appeal (Civil Division) M v F & Ors [2011] EWCA Civ 273 (17 March 2011) High Court (Administrative Court) Johnson , Re [2011] EWHC 593 (Admin) (17 March 2011) Q, R (on the application of) v Q Constabulary & Anor [2011] EWHC 592 (Admin) (17 March 2011) Hinds, R (on the application of) v Blackpool Council [2011] EWHC 591 (Admin) (17 March 2011) High Court (Chancery Division) The Lorenz Consultancy Ltd. v Fox-Davies Capital Ltd. [2011] EWHC 574 (Ch) (17 March 2011) Carey Group Plc… [read post]